U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C15H12F2N4O
Molecular Weight 302.2788
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of N<sup>4</sup>-(3,4-Difluorophenyl)-7-methoxy-4,6-quinazolinediamine

SMILES

COC1=CC2=C(C=C1N)C(NC3=CC(F)=C(F)C=C3)=NC=N2

InChI

InChIKey=GUVPDXOZKDIGIV-UHFFFAOYSA-N
InChI=1S/C15H12F2N4O/c1-22-14-6-13-9(5-12(14)18)15(20-7-19-13)21-8-2-3-10(16)11(17)4-8/h2-7H,18H2,1H3,(H,19,20,21)

HIDE SMILES / InChI

Approval Year

Unknown
139594
Name Type Language
N<sup>4</sup>-(3,4-Difluorophenyl)-7-methoxy-4,6-quinazolinediamine
Common Name English
Dacomitinib Impurity SFAJ
Common Name English
4,6-Quinazolinediamine, N<sup>4</sup>-(3,4-difluorophenyl)-7-methoxy-
Systematic Name English
N<sup>4</sup>-(3,4-Difluorophenyl)-7-methoxyquinazoline-4,6-diamine
Systematic Name English
Code System Code Type Description
CAS
2117703-26-9
Created by admin on Sat Dec 16 19:48:19 GMT 2023 , Edited by admin on Sat Dec 16 19:48:19 GMT 2023
PRIMARY
PUBCHEM
163198491
Created by admin on Sat Dec 16 19:48:19 GMT 2023 , Edited by admin on Sat Dec 16 19:48:19 GMT 2023
PRIMARY
FDA UNII
LKB9X3F9V8
Created by admin on Sat Dec 16 19:48:19 GMT 2023 , Edited by admin on Sat Dec 16 19:48:19 GMT 2023
PRIMARY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966